Brief: Onxeo End-December Cash Position At EUR 17.9 Million
April 6 (Reuters) - Onxeo SA ALONX.PA :
* CASH POSITION OF EUR 17.9 MILLION AS OF DECEMBER 31, 2021
* ANNOUNCES ADDITIONAL FINANCING OF EUR 12 MILLION
* FINANCIAL VISIBILITY EXTENDED TO 2(ND) QUARTER OF 2023
* REVENUES FOR FULL-YEAR 2021 TOTALED EUR 4.1 MILLION
* 2021 OPERATING EXPENSES WERE STABLE ON PREVIOUS YEAR AT
EUR 9.7
MILLION
Source text for Eikon: ID:nBwtXYFta
Further company coverage: ALONX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln